Understanding the epigenetic syntax for the genetic alphabet in the kidney

Journal of the American Society of Nephrology

Volumn 25, Issue 1, 2014, Pages 10-17

  Susztak, Katalin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; HISTONE; LYSINE; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; CELL DIFFERENTIATION; CELL DIVISION; CELL METABOLISM; CELL PROLIFERATION; CHROMATIN; CHROMATIN STRUCTURE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DNA METHYLATION; DNA SEQUENCE; DNA TEMPLATE; ENHANCER REGION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GLOMERULOSCLEROSIS; HEREDITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; HYPERTENSION; IMMUNOPRECIPITATION; INSULIN RELEASE; INTRAUTERINE GROWTH RETARDATION; KIDNEY; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY HYPERTROPHY; MASS SPECTROMETRY; NONHUMAN; NUTRIENT AVAILABILITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY DNA SEQUENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; SUMOYLATION; UTERUS;

EID: 84891780414     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050461     Document Type: Review

References (43)

1. Woroniecki R, Gaikwad AB, Susztak K: Fetal environment, epigenetics, and pediatric renal disease. Pediatr Nephrol 26: 705-711, 2011
2. Mohtat D, Susztak K: Fine tuning gene expression: the epigenome. Semin Nephrol 30: 468-476, 2010
3. Ram O, Goren A, Amit I, Shoresh N, Yosef N, Ernst J, Kellis M, Gymrek M, Issner R, Coyne M, Durham T, Zhang X, Donaghey J, Epstein CB, Regev A, Bernstein BE: Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 147: 1628-1639, 2011
4. Ernst J, Kheradpour P,Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, CoyneM, KuM, Durham T, KellisM, Bernstein BE: Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43-49, 2011
5. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ, Hirst M, Lander ES, Mikkelsen TS, Thomson JA; The NIH Roadmap Epigenomics Mapping Consortium: The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 28: 1045-1048, 2010
6. Ernst J, Kellis M: Interplay between chromatin state, regulator binding, and regulatory motifs in six human cell types. Genome Res 23: 1142-1154, 2013
7. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, Ching KA, Antosiewicz-Bourget JE, Liu H, Zhang X, Green RD, Lobanenkov VV, Stewart R, Thomson JA, Crawford GE, Kellis M, Ren B: Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112, 2009
8. HeintzmanND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B: Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318, 2007
9. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson EM, Kutyavin T, Lajoie B, Lee BK, Lee K, London D, Lotakis D, Neph S, Neri F, Nguyen ED,Qu H, Reynolds AP, Roach V, Safi A, SanchezME, Sanyal A, Shafer A, Simon JM, Song L, Vong S, Weaver M, Yan Y, Zhang Z, Zhang Z, Lenhard B, TewariM, DorschnerMO,Hansen RS, Navas PA, Stamatoyannopoulos G, Iyer VR, Lieb JD, Sunyaev SR, Akey JM, Sabo PJ, Kaul R, Furey TS, Dekker J, Crawford GE, Stamatoyannopoulos JA: The accessible chromatin landscape of the human genome. Nature 489: 75-82, 2012
10. Pujadas E, Feinberg AP: Regulated noise in the epigenetic landscape of development and disease. Cell 148: 1123-1131, 2012
11. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, PelizzolaM, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF: Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 28: 1097-1105, 2010
12. Gehring M, Reik W, Henikoff S: DNA demethylation by DNA repair. Trends Genet 25: 82-90, 2009
13. Dekker J, Marti-Renom MA, Mirny LA: Exploring the three-dimensional organization of genomes: Interpreting chromatin interaction data. Nat Rev Genet 14: 390-403, 2013
14. Sun L, Goff LA, Trapnell C, Alexander R, Lo KA, Hacisuleyman E, Sauvageau M, Tazon-Vega B, Kelley DR, Hendrickson DG, Yuan B, KellisM, Lodish HF, Rinn JL: Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci U S A 110: 3387-3392, 2013
15. Hoffman MM, Ernst J, Wilder SP, Kundaje A, Harris RS, Libbrecht M, Giardine B, Ellenbogen PM, Bilmes JA, Birney E, Hardison RC,Dunham I, Kellis M, Noble WS: Integrative annotation of chromatin elements from ENCODE data. Nucleic Acids Res 41: 827-841, 2013
16. Tycko B: Allele-specific DNA methylation: Beyond imprinting. Hum Mol Genet 19[R2]: R210-R220, 2010
17. Park JS, Ma W, O'Brien LL, Chung E, Guo JJ, Cheng JG, ValeriusMT,McMahon JA,Wong WH, McMahon AP: Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. Dev Cell 23: 637-651, 2012
18. Chen S, Bellew C, Yao X, Stefkova J, Dipp S, Saifudeen Z, Bachvarov D, El-Dahr SS: Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem286: 32775-32789, 2011
19. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, SandstromR,Qu H, Brody J, Shafer A,Neri F, Lee K, Kutyavin T, Stehling-Sun S, Johnson AK, Canfield TK, Giste E, Diegel M, Bates D, Hansen RS, Neph S, Sabo PJ, Heimfeld S, Raubitschek A, Ziegler S, Cotsapas C, Sotoodehnia N, Glass I, Sunyaev SR, Kaul R, Stamatoyannopoulos JA: Systematic localization of common disease-associated variation in regulatory DNA. Science 337: 1190-1195, 2012
20. Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW: Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet 7: e1002150, 2011
21. Henikoff S: ENCODE and our very busy genome. Nat Genet 39: 817-818, 2007
22. Gerstein MB, Bruce C, Rozowsky JS, Zheng D, Du J, Korbel JO, Emanuelsson O, Zhang ZD, Weissman S, Snyder M: What is a gene, post-ENCODE? History and updated definition. Genome Res 17: 669-681, 2007
23. Weinstock GM: ENCODE: More genomic empowerment. Genome Res 17: 667-668, 2007
24. ENCODE Project Consortium: A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9: e1001046, 2011
25. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, Lacroute P, Leng J, Lian J, Monahan H, O'Geen H, Ouyang Z, Partridge EC, Patacsil D, Pauli F, Raha D, Ramirez L, Reddy TE, Reed B, Shi M, Slifer T, Wang J, Wu L, Yang X, Yip KY, Zilberman-Schapira G, Batzoglou S, Sidow A, Farnham PJ, Myers RM, Weissman SM, Snyder M: Architecture of the human regulatory network derived from ENCODE data. Nature 489: 91-100, 2012
26. DeBerardinis RJ, Thompson CB: Cellular metabolism and disease: What do metabolic outliers teach us? Cell 148: 1132-1144, 2012
27. Thompson CB: Rethinking the regulation of cellular metabolism. Cold Spring Harb Symp Quant Biol 76: 23-29, 2011
28. Carone BR, Fauquier L, Habib N, Shea JM, HartCE, Li R, BockC, LiC, GuH, Zamore PD, Meissner A, Weng Z, Hofmann HA, Friedman N, Rando OJ: Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 143: 1084-1096, 2010
29. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, Greally JM: Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 285: 15111-15118, 2010
30. Guerrero-Bosagna CM, Skinner MK: Environmental epigenetics and phytoestrogen/ phytochemical exposures [published online ahead of print December 27, 2013]. J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb. 2012.12.011
31. Guerrero-Bosagna C, Covert TR, Haque MM, SettlesM,Nilsson EE, AnwayMD, SkinnerMK: Epigenetic transgenerational inheritance of vinclozolin induced mouse adult onset disease and associated spermepigenome biomarkers. Reprod Toxicol 34: 694-707, 2012
32. Perera F, Herbstman J: Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol 31: 363-373, 2011
33. Hostetter TH, Rennke HG, Brenner BM: Compensatory renal hemodynamic injury: A final common pathway of residual nephron destruction. Am J Kidney Dis 1: 310-314, 1982
34. de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Study Research Group: Longterm renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171: 412-420, 2011
35. Villeneuve LM, Natarajan R: The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 299: F14-F25, 2010
36. Ko YASK, Susztak K: Epigenomics: The science of no-longer- "junk" DNA. Why study it in chronic kidney disease? Semin Nephrol 33: 354-362, 2013
37. Li Y, ReddyMA,Miao F, ShanmugamN, Yee JK, Hawkins D, Ren B, Natarajan R: Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation.J BiolChem283: 26771-26781, 2008
38. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J ExpMed 205: 2409-2417, 2008
39. KatoM, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437, 2007
40. Ko YAMD, Suzuki M: Park1 ASD, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter TH, Pullman J, Fazzari M, Verma AK, Zheng D, Greally JM, Susztak K: Cytosine methylation changes of enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 14: R108, 2013
41. Sapienza C, Lee J, Powell J, Erinle O, Yafai F, Reichert J, Siraj ES, Madaio M: DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 6: 20-28, 2011
42. Bechtel W, McGoohan S, Zeisberg EM, Müller GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R, Zeisberg M: Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16: 544-550, 2010
43. Van Beneden K,Mannaerts I, PauwelsM, Van den Branden C, van Grunsven LA: HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogen Tissue Repair 6: 1, 2013